Journey Medical Corporation to Participate in A.G.P.’s Annual Virtual Healthcare Conference
Rhea-AI Summary
Journey Medical (Nasdaq: DERM) announced that Co-Founder, President and CEO Claude Maraoui will participate in a fireside chat at A.G.P.’s Annual Virtual Healthcare Conference on May 20, 2026. The virtual session is scheduled for 5:00 p.m. ET, with registration via the A.G.P. conference link.
Positive
- None.
Negative
- None.
News Market Reaction – FBIO
In the May 20 session, FBIO gained 4.74%, reflecting a moderate positive market reaction. Argus tracked a peak move of +3.7% during that session. Our momentum scanner triggered 8 alerts that day, indicating moderate trading interest and price volatility.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Historical Context
| Date | Event | Sentiment | 24h Move | Catalyst |
|---|---|---|---|---|
| May 18 | Conference participation | Neutral | +2.9% | Announced CEO fireside chat at A.G.P.’s Annual Virtual Healthcare Conference. |
| May 14 | Earnings results | Positive | +4.8% | Reported Q1 2026 net income, revenue of $16.0 million, and FDA approval of ZYCUBO. |
| May 13 | Earnings results | Positive | +3.1% | Journey Q1 2026 revenue growth, narrowed net loss, and positive Adjusted EBITDA. |
| May 6 | Earnings date notice | Neutral | -5.9% | Announced timing of Journey’s Q1 2026 results release and conference call. |
| May 4 | Conference participation | Neutral | +2.1% | CEO scheduled for fireside chat at H.C. Wainwright virtual conference. |
24h Move is the share-price change in the day after each event; other market factors may also have contributed.
Recent news and conference-related items for FBIO and Journey often saw positive price reactions, while an earnings date notice drew a negative move.
Across recent items tied to Fortress Biotech (FBIO) and Journey Medical, the stock often reacted positively to earnings and conference participation. The May 14, 2026 FBIO Q1 results and the May 13, 2026 Journey Q1 results both saw gains, as did multiple conference announcements on May 4 and May 18, 2026. In contrast, the earnings date announcement on May 6, 2026 coincided with a decline, highlighting some event-specific volatility around scheduled financial updates.
AI-generated analysis. How Rhea-AI works. Not financial advice.
SCOTTSDALE, Ariz., May 19, 2026 (GLOBE NEWSWIRE) -- Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical,” “the Company,” “we” or “our”), a commercial-stage pharmaceutical company focused on developing, selling and marketing FDA-approved prescription pharmaceutical products for the treatment of dermatological conditions, today announced that Claude Maraoui, Co-Founder, President and Chief Executive Officer, will participate in a fireside chat at A.G.P.’s Annual Virtual Healthcare Conference, taking place on Wednesday, May 20, 2026. The fireside chat is scheduled to begin at 5:00pm ET.
To register for the conference, visit the A.G.P. Registration Link.
About Journey Medical Corporation
Journey Medical Corporation (Nasdaq: DERM) (“Journey Medical”) is a commercial-stage pharmaceutical company that primarily focuses on developing, selling and marketing FDA-approved prescription pharmaceutical products for the treatment of dermatological conditions through its efficient sales and marketing model. The Company currently markets eight branded FDA-approved prescription drugs that help treat and heal common skin conditions. The Journey Medical team comprises industry experts with extensive experience in developing and commercializing some of dermatology’s most successful prescription brands. Journey Medical is located in Scottsdale, Arizona and was founded by Fortress Biotech, Inc. (Nasdaq: FBIO). Journey Medical’s common stock is registered under the Securities Exchange Act of 1934, as amended, and it files periodic reports with the U.S. Securities and Exchange Commission (“SEC”). For additional information about Journey Medical, visit www.journeymedicalcorp.com.
Company Contact:
Jaclyn Jaffe
(781) 652-4500
ir@jmcderm.com
Media Relations Contact:
Tony Plohoros
6 Degrees
(908) 591-2839
tplohoros@6degreespr.com
